The US army has offered to make corona vaccines from Janssen in Leiden available to South Korea. Washington’s crucial Asian ally is itself struggling with a vaccine shortage.
According to sources from Yonhap news agency, the South Koreans can expect around 13,000 doses of the Leiden drug, which is internationally known as the Johnson & Johnson vaccine. The South Korean army is still consulting with health services about how those vaccines will be used in the future.
The US also uses the Janssen vaccine to vaccinate its citizens, but domestic production of the drug is struggling to get off the ground. The Washington Post newspaper wrote last week that all doses used had to be imported from the Netherlands. The American producer Emergent BioSolutions is facing production problems.
The US authorities also stopped the use of the drug for a week and a half last month. They used that period to investigate further possible side effects. Experts concluded that the benefits far outweigh the risks, and the stinging could resume at the end of April.
Yonhap writes that the Janssen vaccine has also been used to vaccinate US forces in South Korea. Unlike many other vaccines, it only needs to be administered once.
If the US also shares the vaccines with the South Korean authorities, they are likely to be used primarily to vaccinate civilians. The South Korean Ministry of Defense has already secured vaccines for its military. These are injected with the means of Pfizer and AstraZeneca.